VIP
NVO

Vantage Investment Partners’s Novo Nordisk NVO Stock Holding History

Vantage Investment Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-549,469
Closed -$28M – 65
2025
Q4 		$28M Buy
549,469
+15,904
+3% +$813K 1.87% 20
2025
Q3 		$29.6M Buy
533,565
+79,441
+17% +$4.65M 2.02% 20
2025
Q2 		$31.3M Sell
454,124
-5,563
-1% -$378K 2.28% 19
2025
Q1 		$31.9M Sell
459,687
-120,730
-21% -$9.97M 2.68% 17
2024
Q4 		$49.9M Buy
580,417
+151,620
+35% +$16.4M 4.35% 4
2024
Q3 		$51.1M Sell
428,797
-105,974
-20% -$14.1M 4.29% 5
2024
Q2 		$76.3M Sell
534,771
-65,020
-11% -$8.62M 6.92% 2
2024
Q1 		$77M Buy
599,791
+116,681
+24% +$13.9M 6.88% 1
2023
Q4 		$50M Buy
483,110
+175,378
+57% +$17.3M 4.98% 2
2023
Q3 		$28M Sell
307,732
-14,890
-5% -$1.31M 3.67% 6
2023
Q2 		$26.1M Buy
322,622
+13,728
+4% +$1.12M 3.38% 9
2023
Q1 		$24.4M Sell
308,894
-58,500
-16% -$4.15M 3.34% 10
2022
Q4 		$24.9M Sell
367,394
-32,454
-8% -$1.9M 3.86% 6
2022
Q3 		$19.9M Sell
399,848
-578,374
-59% -$31M 3.12% 10
2022
Q2 		$54.5M Hold
978,222
– – 4.35% 7
2022
Q1 		$54.3M Buy
+978,222
New +$50.2M 2.71% 13

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Vantage Investment Partners's NVO Position: Q1 2026 in Review

Vantage Investment Partners sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 549,469 shares — an estimated $28M sold.

Vantage Investment Partners first reported a position in NVO in Q1 2022 and held it in 16 quarters. The position peaked at $77M in Q1 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Vantage Investment Partners reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Vantage Investment Partners sold 549,469 Novo Nordisk shares in Q1 2026, an estimated $28M.
  • Vantage Investment Partners first reported a position in Novo Nordisk in Q1 2022 and held it in 16 quarters.
  • Vantage Investment Partners's Novo Nordisk position peaked at $77M in Q1 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Vantage Investment Partners's 13F filing for Q1 2026, filed 1 May 2026.